UPDATE: Novogen Announces Cantrixil Receives Orphan Drug Designation from FDA for Ovarian Cancer

By: via Benzinga
US-Australian drug discovery company, Novogen (NASDAQ: NVGN), today announced that its subsidiary joint venture company with Yale ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.